×
Back to Agenda
Post COVID: Sites Evolving Role in the Clinical Trial Ecosystem
Session Chair(s)
Cristin MacDonald, PHD
Vice President, Client Delivery, WCG Clinical, United States
Following COVID-19, there is a changing role for Sites in the decision-making framework for the selection, implementation, and use of various technologies for clinical trial execution. We will discuss how Sponsors, CROs and Sites can move forward.
Learning Objective : Review the rapid response working group findings as it related to site execution and monitoring during the COVID-pandemic; Discuss how COVID-19 impacted traditional clinical trial execution decision making from dictating to sites how to conduct the research, to including/listening to sites for appropriate next steps; Identify how technology adoption in clinical trial execution will be decided upon.
Speaker(s)
Greg Tuyteleers
Global Operations Head Managed Access and Global Lead Decentralized Trials, Janssen, Belgium
Panelist
Liz Rogers, MSC
Head of Global Site and Study Operations, Pfizer , United States
Panelist
Andy Lee, MA
Senior Vice President, Head of Global Clinical Trial Operations, Merck & Co., Inc., United States
Panelist
Sandy Smith
Senior Vice President, Clinical Solutions and Strategic Partnerships, WCG , United States
Panelist
Have an account?